Biogen Inc (BIIB)
157.84
-0.17
(-0.11%)
USD |
NASDAQ |
Nov 22, 16:00
158.00
+0.16
(+0.10%)
After-Hours: 20:00
Biogen Free Cash Flow: 1.768B for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.768B |
| June 30, 2024 | 1.468B |
| March 31, 2024 | 1.284B |
| December 31, 2023 | 1.236B |
| September 30, 2023 | 1.026B |
| June 30, 2023 | 1.123B |
| March 31, 2023 | 1.421B |
| December 31, 2022 | 1.141B |
| September 30, 2022 | 2.173B |
| June 30, 2022 | 2.315B |
| March 31, 2022 | 2.772B |
| December 31, 2021 | 3.345B |
| September 30, 2021 | 2.107B |
| June 30, 2021 | 2.461B |
| March 31, 2021 | 3.149B |
| December 31, 2020 | 3.678B |
| September 30, 2020 | 5.841B |
| June 30, 2020 | 6.349B |
| March 31, 2020 | 6.282B |
| December 31, 2019 | 6.409B |
| September 30, 2019 | 6.384B |
| June 30, 2019 | 6.324B |
| March 31, 2019 | 5.382B |
| December 31, 2018 | 5.302B |
| September 30, 2018 | 4.855B |
| Date | Value |
|---|---|
| June 30, 2018 | 4.659B |
| March 31, 2018 | 4.671B |
| December 31, 2017 | 2.588B |
| September 30, 2017 | 2.764B |
| June 30, 2017 | 2.126B |
| March 31, 2017 | 2.169B |
| December 31, 2016 | 3.860B |
| September 30, 2016 | 3.509B |
| June 30, 2016 | 3.459B |
| March 31, 2016 | 3.486B |
| December 31, 2015 | 3.261B |
| September 30, 2015 | 3.010B |
| June 30, 2015 | 3.202B |
| March 31, 2015 | 3.211B |
| December 31, 2014 | 2.626B |
| September 30, 2014 | 2.619B |
| June 30, 2014 | 2.359B |
| March 31, 2014 | -1.259B |
| December 31, 2013 | -1.164B |
| September 30, 2013 | -1.515B |
| June 30, 2013 | -1.623B |
| March 31, 2013 | 1.631B |
| December 31, 2012 | 1.625B |
| September 30, 2012 | 1.590B |
| June 30, 2012 | 1.625B |
Free Cash Flow Range, Past 5 Years
1.026B
Minimum
Sep 2023
6.409B
Maximum
Dec 2019
2.867B
Average
2.244B
Median
Free Cash Flow Benchmarks
| Eli Lilly and Co | -2.275B |
| Pfizer Inc | 8.227B |
| Sage Therapeutics Inc | -320.15M |
| Amgen Inc | 6.283B |
| Ionis Pharmaceuticals Inc | -374.21M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 935.60M |
| Cash from Investing (Quarterly) | -1.181B |
| Cash from Financing (Quarterly) | -6.60M |
| Free Cash Flow Per Share (Quarterly) | 5.514 |
| Free Cash Flow to Equity (Quarterly) | 803.70M |
| Free Cash Flow to Firm (Quarterly) | 847.12M |
| Free Cash Flow Yield | 7.68% |